Sinofn Health
Sinofn Health
The global supplement industry is undergoing a paradigm shift from broad-spectrum vitamins to Personalized Precision Nutrition. As an ODM/OEM leader, SINOFN is at the forefront of this transition. By integrating advanced biotechnological processes with traditional health wisdom, we address the critical needs of aging populations and specialized metabolic requirements.
Our R&D roadmap focuses on three core pillars: Bioavailability Enhancement (utilizing advanced liposomal and nano-delivery systems), Microbiome-Friendly Formulations, and Sustainable Green Extraction. We move beyond basic mixing; we engineer health outcomes at the molecular level.
In an era of tightening international regulations (FDA, EFSA, NMPA), SINOFN offers a turnkey compliance ecosystem. We bridge the gap between Asian manufacturing precision and Western regulatory standards. Our BRCGS-certified facilities ensure that every batch, from PKU-specific medical foods to high-purity NMN precursors, meets the highest safety benchmarks.
Led by Dr. Zhang Ying (CAS) and Dr. Tan Shengjie (Peking University), our team integrates clinical medical science with industrial manufacturing, ensuring every product is backed by peer-reviewed research.
Since 2012, we have held 36+ patents. Our foundation is built on scientific collaboration with the Chinese Academy of Sciences, placing us among the top-tier R&D institutions in the supplement sector.
Born from a mission to make PKU medical nutrition affordable, our company culture prioritizes "Profit with Purpose." This ethical mandate permeates our entire manufacturing quality control process.
We maintain an active regulatory monitoring system that maps our production protocols to destination market requirements (e.g., FDA for US, EFSA for Europe). Our factory, certified under ISO 22000 and HACCP, provides full documentation dossiers for seamless customs and market entry.
Our Tianjin R&D center is specifically designed for pilot runs. We can scale from concept to feasibility trial in as little as 4-6 weeks, allowing brands to test market demand before committing to full-scale production runs.
Yes. We leverage our expertise in metabolic disorder formulations and nutraceuticals to help startups optimize their formulas for cost-efficiency without compromising on clinical efficacy. We view our clients as long-term strategic partners.
